Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-FGFR1 (phospho Y653 and Y654) Recombinant Antibody (BA0399) (CBMAB-0293CQ)

Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
BA0399
Antibody Isotype
IgG2b
Application
WB, IHC-P

Basic Information

Immunogen
Corresponding to residues surrounding Tyr653/654 of Human FGFR1
Specificity
Human
Antibody Isotype
IgG2b
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>95% as determined by analysis by SDS-PAGE
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Introduction
The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, FGFR family members differ from one another in their ligand affinities and tissue distribution. This splice variant, termed FGFR1-prime, is expressed in human lung fibroblasts and several other human cell lines. The 2 classes of sequences for recognition and splicing of pre-mRNA in eukaryotes, GT-AG and AT-AC, are characterized by the nearly invariant dinucleotides present at the extreme 5-prime (donor) and 3-prime (acceptor) ends of the intron.The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. The FGFR1-prime variant bound specifically to acidic FGF but ligand binding caused neither receptor autophosphorylation nor activation of phospholipase C (PLC). The authors suggested that the kinase-deficient variant may have an important role in regulating cellular responses elicited by acidic FGF stimulation.
Entrez Gene ID
UniProt ID
Alternative Names
Fibroblast Growth Factor Receptor 1; Basic Fibroblast Growth Factor Receptor 1; Fms-Related Tyrosine Kinase 2; Proto-Oncogene C-Fgr; EC 2.7.10.1; BFGF-R-1; FGFR-1; N-SAM; BFGFR; FGFBR; FLT-2; HBGFR; FLT2; CEK; FLG; Heparin-Binding Growth Factor Receptor; Hydroxyaryl-Protein Kinase; FMS-Like Tyrosine Kinase 2; Fms-Like Tyrosine Kinase 2; FGFR1/PLAG1 Fusion; Pfeiffer Syndrome; CD331 Antigen; EC 2.7.10; HRTFDS; CD331; ECCL; KAL2; HH2; OGD
More Infomation

Zhu, X., Qiu, C., Wang, Y., Jiang, Y., Chen, Y., Fan, L., ... & Yu, L. (2022). FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis. Proceedings of the National Academy of Sciences, 119(26), e2202631119.

Meric-Bernstam, F., Bahleda, R., Hierro, C., Sanson, M., Bridgewater, J., Arkenau, H. T., ... & Goyal, L. (2022). Futibatinib, an irreversible FGFR1–4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study. Cancer discovery, 12(2), 402-415.

Hu, Y., Ai, L. S., & Zhou, L. Q. (2021). Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis. PloS one, 16(5), e0251202.

Pozdnyakova, O., Orazi, A., Kelemen, K., King, R., Reichard, K. K., Craig, F. E., ... & Wang, S. A. (2021). Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2. American journal of clinical pathology, 155(2), 160-178.

Servetto, A., Kollipara, R., Formisano, L., Lin, C. C., Lee, K. M., Sudhan, D. R., ... & Arteaga, C. L. (2021). Nuclear FGFR1 regulates gene transcription and promotes antiestrogen resistance in ER+ breast cancer. Clinical Cancer Research, 27(15), 4379-4396.

Baruch, A., Wong, C., Chinn, L. W., Vaze, A., Sonoda, J., Gelzleichter, T., ... & Arora, P. S. (2020). Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans. Proceedings of the National Academy of Sciences, 117(46), 28992-29000.

Bahleda, R., Meric-Bernstam, F., Goyal, L., Tran, B., He, Y., Yamamiya, I., ... & Arkenau, H. T. (2020). Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors. Annals of Oncology, 31(10), 1405-1412.

Li, J., Liu, H., Srivastava, S. P., Hu, Q., Gao, R., Li, S., ... & Kanasaki, K. (2020). Endothelial FGFR1 (fibroblast growth factor receptor 1) deficiency contributes differential fibrogenic effects in kidney and heart of diabetic mice. Hypertension, 76(6), 1935-1944.

Neocleous, V., Fanis, P., Toumba, M., Tanteles, G. A., Schiza, M., Cinarli, F., ... & Phylactou, L. A. (2020). GnRH deficient patients with congenital hypogonadotropic hypogonadism: novel genetic findings in ANOS1, RNF216, WDR11, FGFR1, CHD7, and POLR3A genes in a case series and review of the literature. Frontiers in endocrinology, 11, 626.

Ryan, M. R., Sohl, C. D., Luo, B., & Anderson, K. S. (2019). The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMTMechanisms of V561M FGFR1–Driven Drug Resistance. Molecular Cancer Research, 17(2), 532-543.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-FGFR1 (phospho Y653 and Y654) Recombinant Antibody (BA0399)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry